WebMar 4, 2024 · PAUL, Minn.-- (BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coronary vascular disease, today announced that it has appointed Jeffery W. Chambers, M.D., as Chief Medical Officer. WebApr 12, 2024 · The Diamondback 360 has a unique Mechanism of Action designed to: Facilitate crown contact with 360 degrees of the vessel wall Differentially sand away arterial calcium from athersclerotic tissue, …
CSI Cardio + Vascular LinkedIn
WebAug 10, 2024 · ST. PAUL, Minn.--(BUSINESS WIRE)--A new sub-analysis from the landmark LIBERTY 360° study, sponsored by Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), was presented today as part of a late ... WebFacilitates 360° crown-vessel contact to sand away arterial calcium; ... CSI, Stealth 360 are registered trademarks belonging to Cardiovascular Systems, Inc. Product codes. CODE: PRODUCT: P-2ST-MI125-145: STEALTH 360 1.25 MICRO CROWN PERIPHERAL OAD: P-2ST-SO125-145: STEALTH 360 1.25 SOLID CROWN PERIPHERAL OAD: brick house with columns on front porch
Cardiovascular Systems, Inc. LinkedIn
WebApr 6, 2024 · For more information about CSI investment opportunities or to request information. Contact us. Contact. CSI Headquarters 1225 Old Highway 8 NW St. Paul, MN 55112 651.259.1600 1.877.CSI.0360. Resources. News Releases; Stock Information; Financial Information; Events & Presentations; Corporate Governance; Investor Resources; WebMay 19, 2015 · data showing that primary treatment with CSI’s Diamondback 360®Orbital Atherectomy System (OAS) improved paclitaxel absorption by 50 percent in calcified cadaveric peripheral arteries.... WebCSI is committed to clinical rigor, constant innovation, and a defining drive to set the standard in safe, effective, economical medical devices that improve patient outcomes. To learn more about... brick house with colorful door